Seqens Seqens

X
[{"orgOrder":0,"company":"Suanfarma","sponsor":"Monteloeder","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"Suanfarma Strengthens Positioning in Clinically Proven Active Nutraceuticals with The Acquisition of Monteloeder","therapeuticArea":"Sleep","highestDevelopmentStatus":"Approved","country":"SPAIN","productType":"Small molecule","productStatus":"Approved","date":"February 2022","url1":"","url2":"","graph1":"Sleep","graph2":"Approved"}]

Find Clinical Drug Pipeline Developments & Deals by Suanfarma

Menu
Loading...
Filters Filter
×
FILTER:
filter Company
    filter Sponsor
      filter Country
        filter Therapeutic Area
          filter Study Phase

            Active Filter(s):

            Companies By Therapeutic Area

            Development Status

            Details:

            The agreement will develop the presence in areas such as weight management, cardiovascular, nutricosmetics, relaxation and sleep enhancement including Relaxplx, which is purified in verbascoside, and is an effective solution to concerns around rest and mental well-being.

            Lead Product(s): Lemon Verbena Extract

            Therapeutic Area: Sleep Product Name: Relaxplx

            Highest Development Status: Approved Product Type: Small molecule

            Recipient: Monteloeder

            Deal Size: Undisclosed Upfront Cash: Undisclosed

            Deal Type: Acquisition February 06, 2022

            Post Enquiry
            POST ENQUIRY